Literature DB >> 23953538

Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis.

M M Wells1, K P Croome, E Boyce, N Chandok.   

Abstract

BACKGROUND: Roux-en-Y choledochojejunostomy and duct-to-duct anastomosis are potential methods for biliary reconstruction in liver transplantation (LT) for recipients with primary sclerosing cholangitis (PSC). However, there is controversy over which method yields superior outcomes. The purpose of this study was to evaluate the outcomes of duct-to-duct versus Roux-en-Y biliary anastomosis in patients undergoing LT for PSC.
METHODS: Studies comparing Roux-en-Y versus duct-to-duct anastomosis during LT for PSC were identified based on systematic searches of 9 electronic databases and multiple sources of gray literature.
RESULTS: The search identified 496 citations, including 7 retrospective series, and 692 patients met eligibility criteria. The use of duct-to-duct anastomosis was not associated with a significant difference in clinical outcomes, including 1-year recipient survival rates (odds ratio [OR], 1.02; 95% confidence interval [CI], 0.65-1.60; P = .95), 1-year graft survival rates (OR, 1.11; 95% CI, 0.72-1.71; P = .64), risk of biliary leaks (OR, 1.23; 95% CI, 0.59-2.59; P = .33), risk of biliary strictures (OR, 1.99; 95% CI, 0.98-4.06; P = .06), or rate of recurrence of PSC (OR, 0.94; 95% CI, 0.19-4.78; P = .94).
CONCLUSIONS: There were no significant differences in 1-year recipient survival, 1-year graft survival, risk of biliary complications, and PSC recurrence between Roux-en-Y and duct-to-duct biliary anastomosis in LT for PSC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23953538     DOI: 10.1016/j.transproceed.2013.01.066

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Long-term postoperative outcomes of Roux-en-Y cholangiojejunostomy in patients with benign biliary stricture.

Authors:  Paizula Shalayiadang; Aimaiti Yasen; Abduaini Abulizi; Ayifuhan Ahan; Tiemin Jiang; Bo Ran; Ruiqing Zhang; Qiang Guo; Hao Wen; Yingmei Shao; Tuerganaili Aji
Journal:  BMC Surg       Date:  2022-06-16       Impact factor: 2.030

2.  Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation.

Authors:  Siyuan Yao; Shintaro Yagi; Miki Nagao; Ryuji Uozumi; Taku Iida; Sena Iwamura; Yosuke Miyachi; Hisaya Shirai; Atsushi Kobayashi; Shinya Okumura; Yuhei Hamaguchi; Yuuki Masano; Toshimi Kaido; Hideaki Okajima; Shinji Uemoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-23       Impact factor: 3.267

Review 3.  Management of primary sclerosing cholangitis and its complications: an algorithmic approach.

Authors:  Michal Prokopič; Ulrich Beuers
Journal:  Hepatol Int       Date:  2020-12-30       Impact factor: 6.047

Review 4.  Treatment of primary sclerosing cholangitis in children.

Authors:  Trevor J Laborda; M Kyle Jensen; Marianne Kavan; Mark Deneau
Journal:  World J Hepatol       Date:  2019-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.